Company Research Report: PhotoniCare, Inc.

Company Overview

Name: PhotoniCare, Inc.

Mission: To improve clinical outcomes and serve unmet patient and provider needs by translating novel light-based technologies into objective medical practice.

Foundation: Founded in 2013.

Founders: No specific information on the founders available in the provided data.

Key People:

• Cary Vance: President & CEO

• Ryan Shelton, Ph.D.: COO & Co-founder

• Stephen Boppart, M.D., Ph.D.: CMO & Co-founder

• Christine Baker: Chief Financial Officer

• Alex Forward: VP of Product

Headquarters: Champaign, Illinois, USA

Number of Employees: No specific information is available.

Revenue: No specific information is available.

Known For: Revolutionizing healthcare with the OtoSight Middle Ear Scope, a device that uses Optical Coherence Tomography (OCT) to improve diagnosis of middle ear conditions.

Products

Key Product: OtoSight Middle Ear Scope

Product Overview:
The OtoSight Middle Ear Scope is a handheld, FDA-cleared device that provides non-invasive imaging of the middle ear. It utilizes Optical Coherence Tomography (OCT) to offer high-resolution depth imaging, enabling healthcare providers to assess middle ear health with over 90% accuracy even in the presence of significant earwax. The product aims to eliminate subjectivity in diagnosing middle ear conditions, providing a comprehensive assessment swiftly.

Key Features:
1. Compact Design: Handheld, mobile, and stand-based for easy movement.
2. Demonstrable Impact: Provides objective data for middle ear issues, improving antibiotic prescription accuracy and aiding in assessments of hearing loss, chronic infections, and related learning disabilities.
3. Dual View Capability: Offers true-color video otoscope view and a middle ear scan.
4. Accuracy: 90.6% accuracy in detecting middle ear effusion.

Recent Developments

Rebranding: PhotoniCare recently rebranded its middle ear scope product to the OtoSight Middle Ear Scope to better communicate the tool’s capabilities and technological innovation.

Certification: PhotoniCare completed its ISO 13485:2016 certification for quality management systems, reflecting its commitment to quality in medical device manufacturing.

Partnerships: Steve Meyer, former CEO of Welch Allyn, joined PhotoniCare’s Advisory Board, providing expertise to leverage growth in frontline healthcare innovation.

Awards and Recognition:

• NWA Pitch Competition: Ryan Shelton, CEO, won this competition for tech innovation.

• Funding and Expansion: The company secured over $7 million in funding for the commercial expansion of OtoSight.

Other Achievements:

• Numerous awards for their innovation and execution in medical technology.

• Participation in significant accelerator programs like the Dreamit Ventures accelerator.

Through its flagship product, the OtoSight Middle Ear Scope, PhotoniCare aims to revolutionize diagnosis in otology and pave the way for extending its light-based technology to other medical fields.